Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Published July 2023 | Forecasts through 2027
Benign Prostatic Hypertrophy Implants Market Snapshot
Reports Graph
Overview

This market snapshot from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. 

This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:

  • Unit volumes from 2022 to 2027
  • Market forecasts from 2022 to 2027
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups
Buy Benign Prostatic Hypertrophy Implants Market Snapshot
Companies Covered

Butterly Medical

Endotherapeutics

Olympus

ProArc

ProVerum

Teleflex

Urotronic

ZenFlow

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next